Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity

Decreased dihydropyrimidine dehydrogenase enzyme activity is associated with severe fluoropyrimidine-associated toxicity. Four clinically relevant variants in the DPYD gene are associated with decreased dihydropyrimidine dehydrogenase activity. However, only ∼25% of DPYD variant carriers show a decr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ockeloen, Charlotte W, Raaijmakers, Aron, Hijmans-van der Vegt, Manon, Bierau, Jörgen, de Vos-Geelen, Judith, Willemsen, Annelieke ECAB, van den Bosch, Bianca JC, Coenen, Marieke JH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749565/
https://www.ncbi.nlm.nih.gov/pubmed/34797200
http://dx.doi.org/10.1177/10781552211049144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749565/
https://www.ncbi.nlm.nih.gov/pubmed/34797200
http://dx.doi.org/10.1177/10781552211049144

Ejemplares similares